Onco-Innovations Company Description

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Its lead product candidate is ONC010, a novel inhibitor of the deoxyribonucleic acid repair enzyme polynucleotide kinase 3′-phosphatase in a nanoparticle formulation based on the drug delivery technology.

The company is headquartered in Calgary, Canada.

Onco-Innovations Limited

Country	Canada
Industry	Biological Products, Except Diagnostic Substances
Employees	1
CEO	Thomas O’Shaughnessy

Contact Details

Address: 1309 - 7th Street SW Calgary, British Columbia T2R 1A5 Canada
Website	oncoinnovations.com

Stock Details

Ticker Symbol	ONCO
Exchange	Cboe Canada
Fiscal Year	May - April
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Thomas O’Shaughnessy	Chief Executive Officer
Nico Mah	Chief Financial Officer